Search this Site

Fexofenadine News

Patients With Hay Fever Sleep Better With Intranasal Corticosteroid Spray: Presented at AAAAI

Patients with seasonal allergic rhinitis who use once-daily fluticasone furoate nasal spray report better duration and quality of sleep, fewer symptoms on waking, and better daytime functioning than do similar patients taking...

Pediatric Allegra Marketing Deal Growing

Sciele Pharma has extended a U.S. marketing agreement with sanofi-aventis for Allegra oral suspension by three years.

Fexofenadine safe and well tolerated in young children with allergic rhinitis

Fexofenadine hydrochloride has a good safety profile in treating allergic rhinitis in children 6-24 months of age, researchers report in the December issue of the Annals of Allergy, Asthma, and Immunology.

Ranbaxy gets FDA approval for allergy drug

India's drug major Ranbaxy Laboratories has received tentative approval from the US Food and Drug Administration to manufacture and market a pill to treat rhinitis, one of the most common illnesses in the US.

Help Manage Seasonal Allergy Symptoms In Children

Spring is in the air and for the millions of children suffering from seasonal allergies each year, and their parents, managing symptoms of the condition is important.

Displaying results 1 to 5 out of 20

1

2

3

4

Next >

This site is intended solely for U.S. audiences; products described here may be subject to different medical and/or regulatory requirements in other countries. This site is for educational purposes only; information contained within should not be used to diagnose or treat a health problem or disease. Please consult a licensed health care provider regarding your medical condition.The products mentioned are trademarks of their respective owners.